ABCB1 p.Arg113Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 10506575
[PubMed]
Loo TW et al: "The human multidrug resistance P-glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy."
No.
Sentence
Comment
79
A histidine-tagged Cys-less P-gp containing an R113A mutation and grown in the presence of 2 M MG-132 was assayed for drug-stimulated ATPase activity.
X
ABCB1 p.Arg113Ala 10506575:79:47
status: NEW92 The R113A mutation was included since it stabilizes P-gp against proteolytic digestion during biosynthesis, and it resulted in increased yield of enzyme (23).
X
ABCB1 p.Arg113Ala 10506575:92:4
status: NEW93 Figure 3 shows that the major product of the Cys-less(R113A) mutant in the presence of increasing concentrations of MG-132 was the 150 kDa core-glycosylated intermediate.
X
ABCB1 p.Arg113Ala 10506575:93:54
status: NEW96 Accordingly, the histidine-tagged Cys-less(R113A) P-gp grown with or without 2 M MG-132 was isolated by nickel-chelate chromatography.
X
ABCB1 p.Arg113Ala 10506575:96:43
status: NEW97 As shown in Fig. 4A (lane 4), the 150 kDa core glycosylated Cys-less(R113A) P-gp could be recovered by nickel-chelate chromatography when the mutant was grown with MG-132.
X
ABCB1 p.Arg113Ala 10506575:97:69
status: NEW99 Equivalent amounts of the isolated Cys-less(R113A) P-gps were reconstituted with lipid and assayed for drug-stimulated ATPase activity.
X
ABCB1 p.Arg113Ala 10506575:99:44
status: NEW108 HEK293 cells were transfected with Cys-less P-gp cDNA containing an R113A mutation.
X
ABCB1 p.Arg113Ala 10506575:108:68
status: NEW112 Drug-stimulated ATPase activity of P-gp after expression in the presence or absence of MG-132. HEK293 cells were transfected with pMT21 vector (control) or histidine-tagged Cys-less(R113A) P-gp cDNA (P-gp).
X
ABCB1 p.Arg113Ala 10506575:112:182
status: NEW145 Membranes were prepared from HEK293 cells expressing Cys-less(R113A) P-gp that were grown with or without MG-132.
X
ABCB1 p.Arg113Ala 10506575:145:62
status: NEW170 Protease sensitivity of P-gp after expression in the presence or absence of MG-132. HEK293 cells expressing A52-epitope-tagged Cys-less(R113A) P-gp were treated with (ϩ) or without (-) 2 M MG-132 for 24 h. Membranes were then prepared and treated with various concentrations of TPCK-trypsin.
X
ABCB1 p.Arg113Ala 10506575:170:136
status: NEW
PMID: 9829963
[PubMed]
Loo TW et al: "Quality control by proteases in the endoplasmic reticulum. Removal of a protease-sensitive site enhances expression of human P-glycoprotein."
No.
Sentence
Comment
114
Accordingly, cells expressing a misprocessed mutant (G268V) with or without an additional R113A mutation were radiolabeled with [35 S]methionine and [35 S]cystine to monitor the fate of the mutant.
X
ABCB1 p.Arg113Ala 9829963:114:90
status: NEW116 Fig. 4 shows that there was no detectable difference between the maturation of the core-glycosylated wild type enzyme and the (wild type ϩ R113A) mutant.
X
ABCB1 p.Arg113Ala 9829963:116:145
status: NEW117 By contrast, the core-glycosylated G268V protein failed to mature and was almost undetectable by 24 h. In the double mutant (G268V ϩ R113A), however, there was a 5-10-fold increase in the amount of P-gp at 0 h, but the mutant still failed to mature and was degraded by 24 h. A similar pattern was observed for the processing mutant G269V (data not shown).
X
ABCB1 p.Arg113Ala 9829963:117:139
status: NEW122 The R113A mutation was then introduced to block cleavage of the G341C mutant.
X
ABCB1 p.Arg113Ala 9829963:122:4
status: NEW123 As shown in Fig. 5A (lane 3), the introduction of an R113A mutation significantly affected the synthesis of mutant G341C.
X
ABCB1 p.Arg113Ala 9829963:123:53
status: NEW126 To determine whether the mature mutant protein was functional, the histidine-tagged mutant (G341C ϩ R113A) was expressed in HEK 293 cells and purified by nickel-chelate chromatography.
X
ABCB1 p.Arg113Ala 9829963:126:106
status: NEW129 Mutant (G341C ϩ R113A) exhibited verapamiland vinblastine-stimulated ATPase activities that were similar to the parent enzyme.
X
ABCB1 p.Arg113Ala 9829963:129:22
status: NEW134 FIG. 4. Effect of R113A mutation on maturation of wild type and mutant G268V P-gp. HEK 293 cells expressing wild type or mutant G268V P-gps-A52 and containing Arg113 or R113A were pulse-labeled for 20 min at 37 °C and then chased with fresh media for the various intervals (hr).
X
ABCB1 p.Arg113Ala 9829963:134:18
status: NEWX
ABCB1 p.Arg113Ala 9829963:134:169
status: NEW137 FIG. 5. Effect of R113A mutation on maturation and drug-stimulated ATPase activity of mutant G341C.
X
ABCB1 p.Arg113Ala 9829963:137:18
status: NEW138 A, HEK 293 cells expressing P-gp-A52 mutants G341C or G341C ϩ R113A in Cys-less background were grown with (ϩ) or without (-) 10 M cyclosporin A for 24 h. Equivalent amounts of whole cell extracts were subjected to immunoblot analysis with monoclonal antibody A52.
X
ABCB1 p.Arg113Ala 9829963:138:68
status: NEW139 B, purified histidine-tagged Cys-less or mutant G341C ϩ R113A (in Cys-less background P-gp) were added to lipid and assayed for ATPase with or without verapamil (1 mM, shaded bars) or vinblastine (0.05 mM, unshaded bars).
X
ABCB1 p.Arg113Ala 9829963:139:62
status: NEW148 Apparently, the G341C mutation does not cause complete misfolding of the protein because introduction of an additional R113A mutation to prevent degradation converts the mutant to a functional enzyme with characteristics indistinguishable from parent enzyme (Fig. 5B).
X
ABCB1 p.Arg113Ala 9829963:148:119
status: NEW